When Caregivers and Biopharma Companies Collaborate
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
When Caregivers and Biopharma Companies Collaborate
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Collaboration between caregivers and biopharma companies can lead to innovations that benefit both the patient and their support systems, leading to better health outcomes, more effective therapies, and a higher quality of life for all involved. In this special Rare Disease Day 2025 podcast you will hear the story of Ron and Marla Chapleau and how they have cared for their Aiden who has an ultrarare neurodegenerative disease for over two decades. You will also hear how one company, Vigil Neuroscience, is developing a therapy to help treat Aiden’s condition and the strong bond that has developed between Vigil and the Chapleau family. to learn more, go to insickness.org.
Ce que les auditeurs disent de When Caregivers and Biopharma Companies Collaborate
Moyenne des évaluations de clientsÉvaluations – Cliquez sur les onglets pour changer la source des évaluations.
Il n'y a pas encore de critiques pour ce titre.